User Image Cart Icon 0 Search Image
  • Home > Blog > Neurochemistry Of Addiction

Neurochemistry Of Addiction

  1. Microdialysis and the NEUROCHEMISTRY of addiction
  2. NEUROCHEMISTRY of addiction : monitoring essential neurotransmitters of addiction
  3. addiction : Imaging in clinical neuroscience
  4. Sex addiction and women: A nursing issue
  5. Basic NEUROCHEMISTRY: principles of molecular, cellular, and medical neurobiology
  6. Understanding the means and objects of addiction : Technology, the internet, and gambling
  7. NEUROCHEMISTRY of addiction
  8. Educating treatment professionals about addiction science research: demographics of knowledge and belief changes
  9. A neurochemical basis for alcohol and other drug addiction
  10. Variations in addiction : The molecular and the molar in neuroscience and pain medicine
  11. Conclusion: Defining the Future of addiction Research in South and East Africa
  12. addiction in South and East Africa
  13. Anne Lingford-Hughes: to get into addiction , just say yes
  14. Introduction: Making a Case for addiction in Africa
  15. The neural substrates of addiction
  16. Sexual addiction & Its Treatment
  17. Pain management and the so-called “risk” of addiction
  18. The most important unresolved issue in the addiction s: conceptual chaos
  19. Opioid maintenance, weaning and detoxification techniques: where we have been, where we are now and what the future holds
  20. Review of neurotransmitters and their role in alcoholism treatment
  21. addiction to food and brain reward systems
  22. addiction : Reward, motivation and stress
  23. A Reply to Wade: ” Say When: Critics Cannot Stop”
  24. The effects of lobeline and naltrexone on methamphetamine-induced place preference and striatal dopamine and serotonin levels in adolescent rats with a history of …
  25. Advances in the Neuroscience of addiction
  26. Don’t call it love: Recovery from sexual addiction
  27. Drug discovery for the treatment of addiction : medicinal chemistry strategies
  28. addiction medicine: A place for faculty development
  29. Effectiveness of addiction science presentations to treatment professionals, using a modified Solomon study design
  30. Neurochemical Approaches to addiction Treatment
  31. Brain stimulation in the study and treatment of addiction
  32. Ethnopharmacology of love
  33. Rapid detox: understanding new treatment approaches for the addicted patient
  34. Sex addiction : Controversy within mainstream addiction medicine, diagnosis based on the DSM-III-R, and physician case histories
  35. The addiction Conspiracy: Unlocking Brain Chemistry and addiction So You Don’t Have to Struggle
  36. From white bullets to black markets and greened medicine: the neuroeconomics and neuroracial politics of opioid pharmaceuticals
  37. Pearls
  38. No stones: Women redeemed from sexual addiction
  39. Bargains with chaos: Sex addicts and addiction interaction disorder
  40. Traditional and New Treatments of addiction –Ethical and Legal Aspects
  41. Effect of rat parental morphine exposure on passive avoidance memory and morphine conditioned place preference in male offspring
  42. Neurophysiology, Politics and Personhood in Russian addiction Medicine
  43. Review of Two Books on NeuroEconomics
  44. Jeffery Satinover statement to congress on pornography
  45. The ins and outs of the striatum: role in drug addiction
  46. Elasticity and Hegemony: A Brief History of addiction Narrative in the Postwar United States
  47. PERERA, SYLVIA BRINTON. Queen Maeve and Her Lovers. New York: Carrowmore Books, 1999. Pp. 490. Hbk. $39.00
  48. Translational approach to develop novel medications on alcohol addiction : focus on neuropeptides
  49. addiction ‘s defining characteristics
  50. Imaging receptor changes in human drug abusers
  51. Pain and addiction
  52. Behavioural and Pharmacological Assessment of addiction in Planaria
  53. Targeting extinction and reconsolidation mechanisms to combat the impact of drug cues on addiction
  54. addiction for nurses
  55. Fifty years in the development of a glutaminergic-dopaminergic optimization complex (KB220) to balance brain reward circuitry in reward deficiency syndrome …
  56. Learning to forget: manipulating extinction and reconsolidation processes to treat addiction
  57. “Diminished Impressibility”: addiction , Neuroadaptation, and Pleasure in Coleridge
  58. Seminar on addictive disorders: An exploration of students’ knowledge, attitudes, and behavior
  59. Economic models of pathological gambling
  60. The pharmacology of alcohol and drugs of abuse and addiction
  61. … And if that doesn’t work: A seminar for clergy designed to help with the understanding, diagnosing and treating of the bio-psycho-spiritual disease of …
  62. How to change Michael Pollan’s mind: a critical analysis of ‘addiction ‘, spirituality, and psychedelics
  63. Interview with Dr. Vincent Dole, MD Methadone: The Next 30 Years
  64. SPECT neuroimaging in translational research of CNS disorders
  65. The management of acute dental pain in the recovering alcoholic
  66. addiction s
  67. What can neuroscience tell us about the potential of psychedelics in healthcare? How the neurophenomenology of psychedelics research could help us to flourish …
  68. Neuroeconomics
  69. Suggestions for changes in DSM-III-R criteria for substance use disorders
  70. TIP
  71. Anticraving Effect of Adjunctive Propranolol Administration Prior to Reactivation of addiction Related Memories by Imagery Cues: A Comparative Study
  72. Journeys from addiction to recovery
  73. addiction ‘s defining characteristics.
  74. The substance abuse pandemic: Determinants to guide interventions
  75. Modern disease models of alcoholism and other chemical dependencies: The new biopsychosocial models
  76. Pharmacological aspects of drug dependence: Toward an integrated neurobehavioral approach
  77. The neurochemical investigation and treatment of cocaine addiction using rodent models
  78. The impact of electronic nicotine delivery system (ENDS) flavors on nicotinic acetylcholine receptors and nicotine addiction -related behaviors
  79. Characterizing intercellular signaling peptides in drug addiction
  80. Quality and Performance Improvement: What’sa Program to Do?
  81. Food junkies: Recovery from food addiction
  82. Neuroendocrine correlates of temperament traits in abstinent opiate addicts
  83. Ceftriaxone attenuates locomotor activity induced by acute and repeated cocaine exposure in mice
  84. Effectiveness of outreach to homeless substance abusers
  85. A novel highly selective 5-HT6 receptor antagonist attenuates ethanol and nicotine seeking but does not affect inhibitory response control in Wistar rats
  86. Ethical aspects of developments in neuroscience and drug addiction
  87. Midbrain mutiny: The picoeconomics and neuroeconomics of disordered gambling: Economic theory and cognitive science
  88. Emerging pharmacotherapies for smoking cessation
  89. Gamma-aminobutyric acidergic projections from the dorsal raphe to the nucleus accumbens are regulated by neuromedin U
  90. Clinical evaluation of substance abuse
  91. The Behavioral Concepts of Abuse and addiction in Diagnosis
  92. addiction , Alienation and Assertiveness in Saudi and English Drug Addicts
  93. Autonomy and Addictive Design
  94. Front & Back Matter
  95. The impact of technological culture on addiction in twentieth century America
  96. Blockade of D3 receptors by YQA14 inhibits cocaine’s rewarding effects and relapse to drug-seeking behavior in rats
  97. Substance abuse disorders in nurses
  98. 8. Is there an ecstasy (MDMA) dependence syndrome?
  99. A feminist call for transforming the criminal justice system
  100. Spit (smokeless)-tobacco use by baseball players entering the professional ranks
  101. Chemical dependency and relapse prevention: Having fun instead of abstinence
  102. Clinical neuroscience
  103. Advances in genetic studies of substance abuse in China
  104. No stones: Women redeemed from sexual shame
  105. Cytoplasmic Polyadenylation Element Binding Proteins CPEB1 and CPEB3 Regulate the Translation of FosB and Are Required for Maintaining addiction -Like …
  106. N1′-fluoroethyl-naltrindole (BU97001) and N1′-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential δ-opioid receptor PET ligands
  107. Effect of intracerebroventricular injection of GABA receptors antagonists on morphine-induced changes in GABA and GLU transmission within the mPFC: an in …
  108. Effects of dopamine antagonists on alfentanil–induced locomotor activity in horses
  109. On the arterial consequences of smoking
  110. Brain-implantable multifunctional probe for simultaneous detection of glutamate and GABA neurotransmitters
  111. Instagram, addiction , and Spirituality: Remaining Human in a Social Media World
  112. Is ecstasy a drug of dependence?
  113. Straight talk from Claudia Black: what recovering parents should tell their kids about drugs and alcohol
  114. Front & Back Matter
  115. Ethical Implications of Advances in Neuroscience Research on the addiction s
  116. Perinatal Staff Education on Opioid Use Disorder
  117. Alcohol-induced Reward Memory is Positively Associated With Persistent High Levels of RACK1, LC3-II/I and Synaptophysin in Hippocampus of C57BL/6J Mice.
  118. A Neurochemical pattern generator SoC with switched-electrode Management for single-chip electrical stimulation and 9.3 µW, 78 pA rms, 400 V/s FSCV sensing
  119. Evaluation of efavirenz on neurochemical and oxidative stress markers and addictive-like behaviours in rats
  120. Governing desire in the biomolecular era: addiction science and the making of neurochemical subjects
  121. An in vitro comparison of microdialysis relative recovery of Met-and Leu-enkephalin using cyclodextrins and antibodies as affinity agents
  122. Double dissociation between actions of dopamine D1 and D2 receptors of the ventral and dorsolateral striatum to produce reinstatement of cocaine seeking behavior
  123. Overcoming crystal meth addiction : An essential guide to getting clean
  124. Using [11C] diprenorphine to image opioid receptor occupancy by methadone in opioid addiction : clinical and preclinical studies
  125. Hypothesizing that a pro-dopaminergic regulator (KB220z™ Liquid Variant) can induce “dopamine homeostasis” and provide adjunctive detoxification …
  126. Investigation of Carbamathione Pharmacokinetics and Pharmacodynamics by In Vivo Microdialysis and Capillary Electrophoresis
  127. The potential rewarding and reinforcing effects of the substituted benzofurans 2-EAPB and 5-EAPB in rodents
  128. The heart of darkness: a journey into chronic sexual addiction and the quest for recovery
  129. STIMULANTS: NEUROIMAGING AND TREATMENTS
  130. Attentional functioning among polysubstance-abusing adolescents: Heroin users versus non-heroin users and implications for school-based learning
  131. The Spiritual Recovery Manual: Vedic Knowledge and Yogic Techniques to Accelerate Recovery
  132. Problematic internet use in turkish high school students: prevalence and related factors
  133. Lesion of medial prefrontal cortex reduces morphine-induced extracellular dopamine level in the ventral tegmental area: a microdialysis study in rats
  134. Integrated Microsystems for High-Fidelity Sensing and Manipulation of Brain NEUROCHEMISTRY
  135. The Epigenome: Possible Mechanisms by which Early Life Stress May Prime Vulnerability towards Substance Use Disorder
  136. A postmarketing surveillance program to monitor Ultram®(tramadol hydrochloride) abuse in the United States
  137. Subject Guides: Neurosurgery: Home
  138. A group intervention targeting substance abuse in low-income communities
  139. The novel modafinil analog, JJC8-016, as a potential cocaine abuse pharmacotherapeutic
  140. The role of GABAB receptors in morphine self-administration
  141. Literature Calling: A Review of Recent Publications of Interest to Functional Neurology
  142. “Waltzing with the Monster,” Interventions with the Substance-Abusing Adolescent for Pastors, Treatment Providers, and Family
  143. Nicotine addiction : Behavioural and Neurochemical Mechanisms
  144. Unprotected anal intercourse in HIV‐infected and non‐HIV‐infected gay men
  145. Moral Mode Switching: From Punishment to Public Health
  146. Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission
  147. Taming Nicotine: Big Tobacco’s Quest to Hide and Harness addiction
  148. Core curriculum of addiction s nursing: An official publication of the IntNSA
  149. Do morphine and its metabolites morphine-6-glucuronide and morphine-3-glucuronide affect dopamine release in nucleus accumbens in mice?
  150. Glutamate transporter subtype 1 (GLT-1) activator ceftriaxone attenuates amphetamine-induced hyperactivity and behavioral sensitization in rats
  151. TOBACCO CESSATION
  152. National Drug Control Strategy: 1999
  153. Extinction training following cocaine or MDMA self-administration produces discrete changes in D2-like and mGlu5 receptor density in the rat brain
  154. What is comorbidity and why does it occur?
  155. Effects of gaboxadol on the expression of cocaine sensitization in rats.
  156. Investigating the microstructural and neurochemical environment within the basal ganglia of current methamphetamine abusers
  157. Cannabis use and cannabis use disorders among individuals with mental illness
  158. Ethanol-sensitive NMDAR-dependent synaptic plasticity and synaptic transmission in the bed nucleus of the stria terminals
  159. Fabrication of Highly Sensitive Pt-black Electrochemical Sensors for GABA Detection
  160. Wireless integrated microsystems for monitoring brain chemical and electrical activity
  161. Research into the place of nutritional therapy and exercise therapy in a program of recovery from substance addiction and process addiction
  162. Neurotensin in the ventral pallidum increases extracellular γ-aminobutyric acid and differentially affects cue-and cocaine-primed reinstatement
  163. Animal well-being and behavioural needs on the farm
  164. The National Drug Control Strategy, 1998: A Ten Year Plan
  165. Potential non-hypoxic/ischemic causes of increased cerebral interstitial fluid lactate/pyruvate ratio: a review of available literature
  166. Quinine enhances the behavioral stimulant effect of cocaine in mice
  167. Enhanced microdialysis sampling of neuropeptides using affinity agents
  168. The chemical tools for imaging dopamine release
  169. Inhibition of monoacylglycerol lipase reduces the reinstatement of methamphetamine-seeking and anxiety-like behaviors in methamphetamine self-administered rats
  170. Mass spectrometric detection of neuropeptides using affinity-enhanced microdialysis with antibody-coated magnetic nanoparticles
  171. Nicotinamide co-administration with methamphetamine: Effects on the P450 and dopaminergic systems
  172. Melatonin does not produce sedation in rats: A chronobiological study
  173. Nasal Spray Can Save Lives: Engaging Emergency Department Nurses in the Provision of Naloxone Nasal Spray to High Risk Patients
  174. Characterization of ultrananocrystalline diamond microsensors for in vivo dopamine detection
  175. A novel microbiosensor microarray for continuous ex vivo monitoring of gamma-aminobutyric acid in real-time
  176. Topiramate-phentermine combinations reduce cocaine self-administration in humans
  177. Mass spectrometric characterization of the crustacean neuropeptidome
  178. Animal well-being and behavioural needs on the farm
  179. Interactive effects of morphine and nicotine on memory function depend on the central amygdala cannabinoid CB1 receptor function in rats
  180. Dopamine and binge eating behaviors
  181. Sandrine Parrot and Bernard Renaud
  182. Success factors in smoking cessation: Age, gender, socioeconomic status and readiness for change
  183. Improving in situ electrode calibration with principal component regression for fast-scan cyclic voltammetry
  184. Experimental evaluation and computational modeling of tissue damage from low-flow push–pull perfusion sampling in vivo
  185. IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TEXAS SAN ANTONIO DIVISION
  186. Does enhancing the self-efficacy of participants in smoking cessation programs reduce relapse?
  187. Modafinil activates phasic dopamine signaling in dorsal and ventral striata
  188. Analytical considerations for microdialysis sampling
  189. Smokeless tobacco use among Big Ten wrestlers and factors associated with use
  190. Arousal theory and the interrelationships of caffeine, nicotine and impulsivity
  191. Advances in mass spectrometric tools for probing neuropeptides
  192. Alcohol, cannabis and tobacco use and the mental health of Australians: A comparative analysis of their associations with other drug use, affective and anxiety …
  193. High-resolution 4D PET image reconstruction with the Quad-HIDAC
  194. Chronic infection with Mycobacterium lepraemurium induces alterations in the hippocampus associated with memory loss
  195. Technological evolution of wireless neurochemical sensing with fast-scan cyclic voltammetry
  196. Characterizing Self-Inserting Carbon-Fiber Microelectrode Arrays for Fast-Scan Cyclic Voltammetry
  197. New techniques, applications and perspectives in neuropeptide research
  1. Microdialysis and the NEUROCHEMISTRY of addiction
  2. NEUROCHEMISTRY of addiction : monitoring essential neurotransmitters of addiction
  3. addiction : Imaging in clinical neuroscience
  4. Sex addiction and women: A nursing issue
  5. Basic NEUROCHEMISTRY: principles of molecular, cellular, and medical neurobiology
  6. Understanding the means and objects of addiction : Technology, the internet, and gambling
  7. NEUROCHEMISTRY of addiction
  8. Educating treatment professionals about addiction science research: demographics of knowledge and belief changes
  9. A neurochemical basis for alcohol and other drug addiction
  10. Variations in addiction : The molecular and the molar in neuroscience and pain medicine
  11. Conclusion: Defining the Future of addiction Research in South and East Africa
  12. addiction in South and East Africa
  13. Anne Lingford-Hughes: to get into addiction , just say yes
  14. Introduction: Making a Case for addiction in Africa
  15. The neural substrates of addiction
  16. Sexual addiction & Its Treatment
  17. Pain management and the so-called “risk” of addiction
  18. The most important unresolved issue in the addiction s: conceptual chaos
  19. Opioid maintenance, weaning and detoxification techniques: where we have been, where we are now and what the future holds
  20. Review of neurotransmitters and their role in alcoholism treatment
  21. addiction to food and brain reward systems
  22. addiction : Reward, motivation and stress
  23. A Reply to Wade: ” Say When: Critics Cannot Stop”
  24. The effects of lobeline and naltrexone on methamphetamine-induced place preference and striatal dopamine and serotonin levels in adolescent rats with a history of …
  25. Advances in the Neuroscience of addiction
  26. Don’t call it love: Recovery from sexual addiction
  27. Drug discovery for the treatment of addiction : medicinal chemistry strategies
  28. addiction medicine: A place for faculty development
  29. Effectiveness of addiction science presentations to treatment professionals, using a modified Solomon study design
  30. Neurochemical Approaches to addiction Treatment
  31. Brain stimulation in the study and treatment of addiction
  32. Ethnopharmacology of love
  33. Rapid detox: understanding new treatment approaches for the addicted patient
  34. Sex addiction : Controversy within mainstream addiction medicine, diagnosis based on the DSM-III-R, and physician case histories
  35. The addiction Conspiracy: Unlocking Brain Chemistry and addiction So You Don’t Have to Struggle
  36. From white bullets to black markets and greened medicine: the neuroeconomics and neuroracial politics of opioid pharmaceuticals
  37. Pearls
  38. No stones: Women redeemed from sexual addiction
  39. Bargains with chaos: Sex addicts and addiction interaction disorder
  40. Traditional and New Treatments of addiction –Ethical and Legal Aspects
  41. Effect of rat parental morphine exposure on passive avoidance memory and morphine conditioned place preference in male offspring
  42. Neurophysiology, Politics and Personhood in Russian addiction Medicine
  43. Review of Two Books on NeuroEconomics
  44. Jeffery Satinover statement to congress on pornography
  45. The ins and outs of the striatum: role in drug addiction
  46. Elasticity and Hegemony: A Brief History of addiction Narrative in the Postwar United States
  47. PERERA, SYLVIA BRINTON. Queen Maeve and Her Lovers. New York: Carrowmore Books, 1999. Pp. 490. Hbk. $39.00
  48. Translational approach to develop novel medications on alcohol addiction : focus on neuropeptides
  49. addiction ‘s defining characteristics
  50. Imaging receptor changes in human drug abusers
  51. Pain and addiction
  52. Behavioural and Pharmacological Assessment of addiction in Planaria
  53. Targeting extinction and reconsolidation mechanisms to combat the impact of drug cues on addiction
  54. addiction for nurses
  55. Fifty years in the development of a glutaminergic-dopaminergic optimization complex (KB220) to balance brain reward circuitry in reward deficiency syndrome …
  56. Learning to forget: manipulating extinction and reconsolidation processes to treat addiction
  57. “Diminished Impressibility”: addiction , Neuroadaptation, and Pleasure in Coleridge
  58. Seminar on addictive disorders: An exploration of students’ knowledge, attitudes, and behavior
  59. Economic models of pathological gambling
  60. The pharmacology of alcohol and drugs of abuse and addiction
  61. … And if that doesn’t work: A seminar for clergy designed to help with the understanding, diagnosing and treating of the bio-psycho-spiritual disease of …
  62. How to change Michael Pollan’s mind: a critical analysis of ‘addiction ‘, spirituality, and psychedelics
  63. Interview with Dr. Vincent Dole, MD Methadone: The Next 30 Years
  64. SPECT neuroimaging in translational research of CNS disorders
  65. The management of acute dental pain in the recovering alcoholic
  66. addiction s
  67. What can neuroscience tell us about the potential of psychedelics in healthcare? How the neurophenomenology of psychedelics research could help us to flourish …
  68. Neuroeconomics
  69. Suggestions for changes in DSM-III-R criteria for substance use disorders
  70. TIP
  71. Anticraving Effect of Adjunctive Propranolol Administration Prior to Reactivation of addiction Related Memories by Imagery Cues: A Comparative Study
  72. Journeys from addiction to recovery
  73. addiction ‘s defining characteristics.
  74. The substance abuse pandemic: Determinants to guide interventions
  75. Modern disease models of alcoholism and other chemical dependencies: The new biopsychosocial models
  76. Pharmacological aspects of drug dependence: Toward an integrated neurobehavioral approach
  77. The neurochemical investigation and treatment of cocaine addiction using rodent models
  78. The impact of electronic nicotine delivery system (ENDS) flavors on nicotinic acetylcholine receptors and nicotine addiction -related behaviors
  79. Characterizing intercellular signaling peptides in drug addiction
  80. Quality and Performance Improvement: What’sa Program to Do?
  81. Food junkies: Recovery from food addiction
  82. Neuroendocrine correlates of temperament traits in abstinent opiate addicts
  83. Ceftriaxone attenuates locomotor activity induced by acute and repeated cocaine exposure in mice
  84. Effectiveness of outreach to homeless substance abusers
  85. A novel highly selective 5-HT6 receptor antagonist attenuates ethanol and nicotine seeking but does not affect inhibitory response control in Wistar rats
  86. Ethical aspects of developments in neuroscience and drug addiction
  87. Midbrain mutiny: The picoeconomics and neuroeconomics of disordered gambling: Economic theory and cognitive science
  88. Emerging pharmacotherapies for smoking cessation
  89. Gamma-aminobutyric acidergic projections from the dorsal raphe to the nucleus accumbens are regulated by neuromedin U
  90. Clinical evaluation of substance abuse
  91. The Behavioral Concepts of Abuse and addiction in Diagnosis
  92. addiction , Alienation and Assertiveness in Saudi and English Drug Addicts
  93. Autonomy and Addictive Design
  94. Front & Back Matter
  95. The impact of technological culture on addiction in twentieth century America
  96. Blockade of D3 receptors by YQA14 inhibits cocaine’s rewarding effects and relapse to drug-seeking behavior in rats
  97. Substance abuse disorders in nurses
  98. 8. Is there an ecstasy (MDMA) dependence syndrome?
  99. A feminist call for transforming the criminal justice system
  100. Spit (smokeless)-tobacco use by baseball players entering the professional ranks
  101. Chemical dependency and relapse prevention: Having fun instead of abstinence
  102. Clinical neuroscience
  103. Advances in genetic studies of substance abuse in China
  104. No stones: Women redeemed from sexual shame
  105. Cytoplasmic Polyadenylation Element Binding Proteins CPEB1 and CPEB3 Regulate the Translation of FosB and Are Required for Maintaining addiction -Like …
  106. N1′-fluoroethyl-naltrindole (BU97001) and N1′-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential δ-opioid receptor PET ligands
  107. Effect of intracerebroventricular injection of GABA receptors antagonists on morphine-induced changes in GABA and GLU transmission within the mPFC: an in …
  108. Effects of dopamine antagonists on alfentanil–induced locomotor activity in horses
  109. On the arterial consequences of smoking
  110. Brain-implantable multifunctional probe for simultaneous detection of glutamate and GABA neurotransmitters
  111. Instagram, addiction , and Spirituality: Remaining Human in a Social Media World
  112. Is ecstasy a drug of dependence?
  113. Straight talk from Claudia Black: what recovering parents should tell their kids about drugs and alcohol
  114. Front & Back Matter
  115. Ethical Implications of Advances in Neuroscience Research on the addiction s
  116. Perinatal Staff Education on Opioid Use Disorder
  117. Alcohol-induced Reward Memory is Positively Associated With Persistent High Levels of RACK1, LC3-II/I and Synaptophysin in Hippocampus of C57BL/6J Mice.
  118. A Neurochemical pattern generator SoC with switched-electrode Management for single-chip electrical stimulation and 9.3 µW, 78 pA rms, 400 V/s FSCV sensing
  119. Evaluation of efavirenz on neurochemical and oxidative stress markers and addictive-like behaviours in rats
  120. Governing desire in the biomolecular era: addiction science and the making of neurochemical subjects
  121. An in vitro comparison of microdialysis relative recovery of Met-and Leu-enkephalin using cyclodextrins and antibodies as affinity agents
  122. Double dissociation between actions of dopamine D1 and D2 receptors of the ventral and dorsolateral striatum to produce reinstatement of cocaine seeking behavior
  123. Overcoming crystal meth addiction : An essential guide to getting clean
  124. Using [11C] diprenorphine to image opioid receptor occupancy by methadone in opioid addiction : clinical and preclinical studies
  125. Hypothesizing that a pro-dopaminergic regulator (KB220z™ Liquid Variant) can induce “dopamine homeostasis” and provide adjunctive detoxification …
  126. Investigation of Carbamathione Pharmacokinetics and Pharmacodynamics by In Vivo Microdialysis and Capillary Electrophoresis
  127. The potential rewarding and reinforcing effects of the substituted benzofurans 2-EAPB and 5-EAPB in rodents
  128. The heart of darkness: a journey into chronic sexual addiction and the quest for recovery
  129. STIMULANTS: NEUROIMAGING AND TREATMENTS
  130. Attentional functioning among polysubstance-abusing adolescents: Heroin users versus non-heroin users and implications for school-based learning
  131. The Spiritual Recovery Manual: Vedic Knowledge and Yogic Techniques to Accelerate Recovery
  132. Problematic internet use in turkish high school students: prevalence and related factors
  133. Lesion of medial prefrontal cortex reduces morphine-induced extracellular dopamine level in the ventral tegmental area: a microdialysis study in rats
  134. Integrated Microsystems for High-Fidelity Sensing and Manipulation of Brain NEUROCHEMISTRY
  135. The Epigenome: Possible Mechanisms by which Early Life Stress May Prime Vulnerability towards Substance Use Disorder
  136. A postmarketing surveillance program to monitor Ultram®(tramadol hydrochloride) abuse in the United States
  137. Subject Guides: Neurosurgery: Home
  138. A group intervention targeting substance abuse in low-income communities
  139. The novel modafinil analog, JJC8-016, as a potential cocaine abuse pharmacotherapeutic
  140. The role of GABAB receptors in morphine self-administration
  141. Literature Calling: A Review of Recent Publications of Interest to Functional Neurology
  142. “Waltzing with the Monster,” Interventions with the Substance-Abusing Adolescent for Pastors, Treatment Providers, and Family
  143. Nicotine addiction : Behavioural and Neurochemical Mechanisms
  144. Unprotected anal intercourse in HIV‐infected and non‐HIV‐infected gay men
  145. Moral Mode Switching: From Punishment to Public Health
  146. Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission
  147. Taming Nicotine: Big Tobacco’s Quest to Hide and Harness addiction
  148. Core curriculum of addiction s nursing: An official publication of the IntNSA
  149. Do morphine and its metabolites morphine-6-glucuronide and morphine-3-glucuronide affect dopamine release in nucleus accumbens in mice?
  150. Glutamate transporter subtype 1 (GLT-1) activator ceftriaxone attenuates amphetamine-induced hyperactivity and behavioral sensitization in rats
  151. TOBACCO CESSATION
  152. National Drug Control Strategy: 1999
  153. Extinction training following cocaine or MDMA self-administration produces discrete changes in D2-like and mGlu5 receptor density in the rat brain
  154. What is comorbidity and why does it occur?
  155. Effects of gaboxadol on the expression of cocaine sensitization in rats.
  156. Investigating the microstructural and neurochemical environment within the basal ganglia of current methamphetamine abusers
  157. Cannabis use and cannabis use disorders among individuals with mental illness
  158. Ethanol-sensitive NMDAR-dependent synaptic plasticity and synaptic transmission in the bed nucleus of the stria terminals
  159. Fabrication of Highly Sensitive Pt-black Electrochemical Sensors for GABA Detection
  160. Wireless integrated microsystems for monitoring brain chemical and electrical activity
  161. Research into the place of nutritional therapy and exercise therapy in a program of recovery from substance addiction and process addiction
  162. Neurotensin in the ventral pallidum increases extracellular γ-aminobutyric acid and differentially affects cue-and cocaine-primed reinstatement
  163. Animal well-being and behavioural needs on the farm
  164. The National Drug Control Strategy, 1998: A Ten Year Plan
  165. Potential non-hypoxic/ischemic causes of increased cerebral interstitial fluid lactate/pyruvate ratio: a review of available literature
  166. Quinine enhances the behavioral stimulant effect of cocaine in mice
  167. Enhanced microdialysis sampling of neuropeptides using affinity agents
  168. The chemical tools for imaging dopamine release
  169. Inhibition of monoacylglycerol lipase reduces the reinstatement of methamphetamine-seeking and anxiety-like behaviors in methamphetamine self-administered rats
  170. Mass spectrometric detection of neuropeptides using affinity-enhanced microdialysis with antibody-coated magnetic nanoparticles
  171. Nicotinamide co-administration with methamphetamine: Effects on the P450 and dopaminergic systems
  172. Melatonin does not produce sedation in rats: A chronobiological study
  173. Nasal Spray Can Save Lives: Engaging Emergency Department Nurses in the Provision of Naloxone Nasal Spray to High Risk Patients
  174. Characterization of ultrananocrystalline diamond microsensors for in vivo dopamine detection
  175. A novel microbiosensor microarray for continuous ex vivo monitoring of gamma-aminobutyric acid in real-time
  176. Topiramate-phentermine combinations reduce cocaine self-administration in humans
  177. Mass spectrometric characterization of the crustacean neuropeptidome
  178. Animal well-being and behavioural needs on the farm
  179. Interactive effects of morphine and nicotine on memory function depend on the central amygdala cannabinoid CB1 receptor function in rats
  180. Dopamine and binge eating behaviors
  181. Sandrine Parrot and Bernard Renaud
  182. Success factors in smoking cessation: Age, gender, socioeconomic status and readiness for change
  183. Improving in situ electrode calibration with principal component regression for fast-scan cyclic voltammetry
  184. Experimental evaluation and computational modeling of tissue damage from low-flow push–pull perfusion sampling in vivo
  185. IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TEXAS SAN ANTONIO DIVISION
  186. Does enhancing the self-efficacy of participants in smoking cessation programs reduce relapse?
  187. Modafinil activates phasic dopamine signaling in dorsal and ventral striata
  188. Analytical considerations for microdialysis sampling
  189. Smokeless tobacco use among Big Ten wrestlers and factors associated with use
  190. Arousal theory and the interrelationships of caffeine, nicotine and impulsivity
  191. Advances in mass spectrometric tools for probing neuropeptides
  192. Alcohol, cannabis and tobacco use and the mental health of Australians: A comparative analysis of their associations with other drug use, affective and anxiety …
  193. High-resolution 4D PET image reconstruction with the Quad-HIDAC
  194. Chronic infection with Mycobacterium lepraemurium induces alterations in the hippocampus associated with memory loss
  195. Technological evolution of wireless neurochemical sensing with fast-scan cyclic voltammetry
  196. Characterizing Self-Inserting Carbon-Fiber Microelectrode Arrays for Fast-Scan Cyclic Voltammetry
  197. New techniques, applications and perspectives in neuropeptide research
Related Posts

Lowering Cholesterol Thru Fasting, Diet & Medicinal Plants

Antifungal Extract

Addiction & Dopamine

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping